Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 4:12 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 601–624 of 4,175 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control comparison Clear all

Conditions: Labor Pain
Interventions: Not listed
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Non Small Cell Lung Cancer
Interventions: AZD6244, docetaxel, Placebo; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 130 Years
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2016
U.S. locations: 4
States / cities: Los Angeles, California • Aurora, Colorado • Boston, Massachusetts + 1 more

Conditions: Chronic Pain
Interventions: SynchroMed Infusion System and Intrathecal Morphine Sulfate, Conventional Medicine; Device · Other
Lead sponsor: MedtronicNeuro; Industry
Eligibility: 18 Years and older
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 6
States / cities: Homewood, Alabama • Napa, California • Walnut Creek, California + 3 more

Conditions: Adolescent Behavior, Risk Behavior, Motivation
Interventions: Integrated personalized feedback; Behavioral
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: 13 Years to 18 Years
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Myopia
Interventions: Phoebe test lens, stenfilcon A lens (control); Device
Lead sponsor: CooperVision, Inc.; Industry
Eligibility: 18 Years to 35 Years
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 1
States / cities: Bloomington, Indiana

Conditions: Gulf War Syndrome
Interventions: Curcumin, Glutathione, Placebo; Drug · Other
Lead sponsor: South Florida Veterans Affairs Foundation for Research and Education; Federal
Eligibility: 35 Years to 70 Years
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Diabetic Foot Ulcer (DFU)
Interventions: Xcell Amnio Matrix, Standard of Care (SOC); Biological · Drug
Lead sponsor: New Horizon Medical Solutions; Network
Eligibility: 18 Years and older
Enrollment: 135 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 3
States / cities: Fresno, California • San Diego, California • Dallas, Texas

Conditions: Sleep, Blood Pressure
Interventions: Sleep Restriction; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 64 Years
Enrollment: 77 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Acquired Hypogonadotropic Hypogonadism, Obesity
Interventions: Placebo, Enclomiphene; Drug
Lead sponsor: Repros Therapeutics Inc.; Industry
Eligibility: 18 Years to 60 Years · Male only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 5
States / cities: Albany, New York • Garden City, New York • Providence, Rhode Island + 2 more

Conditions: Primary Open Angle Glaucoma
Interventions: Canaloplasty using the iTrack microcatheter with Healon GV Pro, Canaloplasty using the Omni surgical system with Healon GV Pro, Canaloplasty using the iTrack microcatheter with Healon Pro, Canaloplasty using the Omni surgical system with Healon Pro; Device
Lead sponsor: Nova Eye, Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 7
States / cities: Glendale, Arizona • Beverly Hills, California • Orange, California + 4 more

Conditions: Mental Disorders
Interventions: Wellness Recovery Action Planning (WRAP); Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 555 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Asthma
Interventions: Jet Nebulizer, Vibrating Mesh Nebulizer; Device
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 2 Years to 18 Years
Enrollment: 220 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Air cleaner, Sham air cleaner; Device
Lead sponsor: JHSPH Center for Clinical Trials; Other
Eligibility: 40 Years and older
Enrollment: 770 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 11
States / cities: Birmingham, Alabama • Los Angeles, California • Iowa City, Iowa + 7 more

Conditions: Breast Cancer, Fatigue, Hypothyroidism
Interventions: physiologic testing, fatigue assessment and management, management of therapy complications; Other · Procedure
Lead sponsor: University of South Florida; Other
Eligibility: 20 Years to 80 Years · Female only
Enrollment: 541 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2015
U.S. locations: 41
States / cities: Phoenix, Arizona • Greeley, Colorado • Loveland, Colorado + 28 more

Conditions: Type 1 Diabetes
Interventions: Terbutaline, 20% basal insulin reduction, Control; Drug · Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 10 Years to 17 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Coronary Artery Disease
Interventions: Prevail DCB, Agent DCB; Device
Lead sponsor: Medtronic Vascular; Industry
Eligibility: 18 Years and older
Enrollment: 1,205 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 55
States / cities: Birmingham, Alabama • Huntsville, Alabama • Tucson, Arizona + 48 more

Conditions: Acne Vulgaris
Interventions: IDP-123 Lotion, Tazorac Cream, Vehicle Lotion, Vehicle Cream; Drug
Lead sponsor: Bausch Health Americas, Inc.; Industry
Eligibility: 12 Years and older
Enrollment: 210 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 16
States / cities: Encinitas, California • Fremont, California • Los Angeles, California + 12 more

Conditions: Plasma Cell Myeloma Refractory
Interventions: Isatuximab, Dexamethasone, Pomalidomide, Belantamab mafodotin, Pegenzileukin, SAR439459, Belumosudil, Evorpacept; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years and older
Enrollment: 258 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2028
U.S. locations: 5
States / cities: Atlanta, Georgia • Chicago, Illinois • Ann Arbor, Michigan + 2 more

Conditions: Chronic Pain, Mental Health Disorders, Behavioral Health Challenges, Ecological Momentary Assessment Best Practices
Interventions: Digital Biopsychosocial Conversational Data Collection Software, Standard Digital Questionnaire Data Collection; Other
Lead sponsor: AugMend Health Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: Communication Research
Interventions: nurse-led communication strategy; Behavioral
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 18 Years and older
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Post Operative Pain, Anesthesia, Nerve Block, Shoulder Osteoarthritis
Interventions: Interscalene Catheter, Exparel Single Shot Interscalene Block; Procedure
Lead sponsor: Melinda Seering; Other
Eligibility: 18 Years to 90 Years
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: ADHD
Interventions: Placebo, 100mg SPN-812, 200mg SPN-812; Drug
Lead sponsor: Supernus Pharmaceuticals, Inc.; Industry
Eligibility: 6 Years to 11 Years
Enrollment: 477 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 7
States / cities: Dothan, Alabama • Hialeah, Florida • Meridian, Idaho + 4 more

Conditions: Asthma
Interventions: Mometasone, Advair; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Opioid Use Disorder, Sleep, Circadian Rhythms, fMRI Research
Interventions: AYO light glasses (experimental), AYO light glasses (comparator); Device
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 60 Years
Enrollment: 105 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Birmingham, Alabama

Search by objective public record fields.

Comparison of Ultrasound Guided Low Epidural Catheter Placement With Standard Epidural Catheter Placement

AZD6244 in Combination With Docetaxel Versus Docetaxel Alone in KRAS Mutation Positive NSCLC Patients

Intrathecal Morphine Compared to Conventional Medical Management for Pain Control and Opioid-related Side Effects

CheckED Yourself Study

Comparison of New Contact Lens With Current Marketed Lens

Glutathione vs. Curcumin Clinical Trial

A Prospective Clinical Study to Evaluate the Effectiveness and Safety of Xcell Amnio MatrixTM (XAM) in the Management of Chronic Non-healing DFUs

Sleep and Social Experiences Study 2

A Multi-Center Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Body Composition and Metabolic Parameters With Diet and Exercise in Conjunction With Treatment With 12.5 mg or 25 mg Enclomiphene

Multicenter Ab-interno Glaucoma Study Investigating Canaloplasty

Randomized Controlled Trial of Wellness Recovery Action Planning

Comparison of Vibrating Mesh Nebulizer Versus Jet Nebulizer in the Pediatric Asthma Patient

Multi-Center Clean Air Randomized Controlled Trial in COPD

Thyroid Dysfunction in Women With Newly Diagnosed Breast Cancer Compared to Healthy Volunteers

Use of Terbutaline or a Reduction in Basal Insulin in the Prevention of Nocturnal Hypoglycemia

Prevail Global Study

Safety and Efficacy of IDP-123 Lotion to Tazorac® Cream, in the Treatment of Acne Vulgaris

Isatuximab in Combination With Novel Agents in RRMM - Master Protocol

Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software

Using a Nurse-Led Communication Strategy for Surrogates in the Intensive Care Unit

Comparison of Interscalene Catheter to Single Injection Interscalene Blocks for Total Shoulder Arthroplasties

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) Low Dose in Children With ADHD

A Comparison of Mometasone to Advair in Patients With Milder Persistent Asthma

The Effect of Light Intervention on Recovery in Individuals With Opioid Use Disorder (OUD)